References


Deprecated: Function eregi_replace() is deprecated in /web/sites/depts/erbc/web/erbc/media_and_info/references.html on line 167

Deprecated: Function eregi_replace() is deprecated in /web/sites/depts/erbc/web/erbc/media_and_info/references.html on line 167

Deprecated: Function eregi_replace() is deprecated in /web/sites/depts/erbc/web/erbc/media_and_info/references.html on line 167

Deprecated: Function eregi_replace() is deprecated in /web/sites/depts/erbc/web/erbc/media_and_info/references.html on line 167

Deprecated: Function eregi_replace() is deprecated in /web/sites/depts/erbc/web/erbc/media_and_info/references.html on line 167

Deprecated: Function eregi_replace() is deprecated in /web/sites/depts/erbc/web/erbc/media_and_info/references.html on line 167

Deprecated: Function eregi_replace() is deprecated in /web/sites/depts/erbc/web/erbc/media_and_info/references.html on line 167

Deprecated: Function eregi_replace() is deprecated in /web/sites/depts/erbc/web/erbc/media_and_info/references.html on line 167

Deprecated: Function eregi_replace() is deprecated in /web/sites/depts/erbc/web/erbc/media_and_info/references.html on line 167

Deprecated: Function eregi_replace() is deprecated in /web/sites/depts/erbc/web/erbc/media_and_info/references.html on line 167

Deprecated: Function eregi_replace() is deprecated in /web/sites/depts/erbc/web/erbc/media_and_info/references.html on line 167

Deprecated: Function eregi_replace() is deprecated in /web/sites/depts/erbc/web/erbc/media_and_info/references.html on line 167

Deprecated: Function eregi_replace() is deprecated in /web/sites/depts/erbc/web/erbc/media_and_info/references.html on line 167

Deprecated: Function eregi_replace() is deprecated in /web/sites/depts/erbc/web/erbc/media_and_info/references.html on line 167

Deprecated: Function eregi_replace() is deprecated in /web/sites/depts/erbc/web/erbc/media_and_info/references.html on line 167

    A

  • Ahlbom, A., Lichtenstein P., Malmstrom, H., Feychting, M., Hemminki, K., and Pedersen, N.L. (1997). Cancer in twins: genetic and nongenetic familial risk factors. Journal of the National Cancer Institute 89: 287-93.
  • Allred, C.D., Allred, K.F., Ju, Y.H., Virant, S.M., and Helferich, W.G. (2001). Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Research 61: 5045-5050.
  • Althuis, M.D., Brogan, D.R., Coates, R.J., Daling, J.R., Gammon, M.D., Malone, K.E., Schoenberg, J.B., and Brinton, L.A. (2003). Hormonal content and potency of oral contraceptives and breast cancer risk among young women. British Journal of Cancer 88: 50-57.
  • Andersen HR, Vinggaard AM, Rasmussen TH, et al. (2002). Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro. Toxicology and Applied Pharmacology 179:1-12.
  • Andersson, P.L., Blom, A., Johannisson, A., Pesonen, M., Tysklind, M., Berg, A.H., Olsson, P.E., and Norrgren, L. (1999). Assessment of PCBs and hydroxylated PCBs as potential xenoestrogens: in vitro studies based on MCF-7 cell proliferation and induction of vitellogenin in primary culture of rainbow trout hepatocytes. Archives of Environmental Contamination and Toxicology 37: 145-150.
  • Andrieu N, Easton DF, Chang-Claud J, Rookus MA, Brohet R, Cardis E et al. (2006). Effect of chest X-rays on the risk of breast cancer among BRCA 1 / 2 mutation carriers in the International BRCA 1 / 2 Carrier Cohort Study: A report from EMBRACE, GEGNNEPSO, GEO-HEBON, and IBCCS Collaborataors
  • Aschengrau, A., Coogan, P.F., Quinn, M., and Cashins, L.J. (1998). Occupational exposure to estrogenic chemicals and the occurrence of breast cancer: an exploratory analysis. American Journal of Industrial Medicine 34: 6-14.
  • Aschengrau, A., Rogers, S., and Ozonoff, D. (2003). Perchloroethylene-contaminated drinking water and the risk of breast cancer: additional results from Cape Cod, Massachusetts, USA. Environmental Health Perspectives 111: 167-173.
  • B

  • Baird, W.M., Hooven, L.A., and Mahadevan, B. (2005). Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environmental and Molecular Mutagenesis 45: 106-114.
  • Bakken, K., Alsaker, E., Eggen, A.E., and Lund, E. (2004). Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study. International Journal of Cancer 112: 130-134.
  • Band, PR., Le, N.D., Fang, R., Deschamps, M., Gallagher, R.P. and Yang, P. (2000). Identification of occupational cancer risks in British Columbia: A population-based case-control study of 995 incident breast cancer cases by menopausal status, controlling for confounding factors. Journal of Occupational and Environmental Medicine 42: 284-310.
  • Band, PR., Le, N.D., Fang, R., and Deschamps, M.(2002). Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet: 1044-1049.
  • Barnes, S. (1997). The chemopreventive properties of soy isoflavonoids in animal models of breast cancer. Breast Cancer Research and Treatment 46: 169-179.
  • Bauer, S., Gusev, B.I., Pivina, L.M., Apsalikov, K.N., and Grosche, B. (2005). Radiation exposure due to local fallout from Soviet atmospheric nuclear weapons testing in Kazakhstan: Solid cancer mortality in the semipalatinsk historical cohort, 1960-1999. Radiation Research 164: 409-419.
  • Bernstein, L., Teal, C.R., Joslyn, S., and Wilson, J. (2003). Ethnicity-related variation in breast cancer risk factors. American Cancer Society 97: 222-229.
  • Berrington de Gonzalez A, Berg C, Visvanathan K, Robson M (2009). Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers. Journal of the National Cancer Institute 101:205-209.
  • Bird, A. (2001). DNA methylation patters and epigenetic memory. Genes and Development 16: 6-21.
  • Biglia N, Sgro L, Defabiani E, et al (2005). The influence of hormone replacement therapy on the pathology of breast cancer. Journal of Cancer Surgery 31:467-472.
  • Birnbaum, L.S. (1994). The mechanism of dioxin toxicity: Relationship to risk assessment. Environmental Health Perspectives 102: 157-167.
  • Blount, B.C., Silva, M.J., Caudill, S.P., Needham, L.L., et.al. (2000). Levels of seven urinary phthalate metabolites in a human reference population. Environmental Health Perspectives 108: 979-982.
  • Boice, J.D. (2001). Radiation and breast carcinogenesis. Medical and Pediatric Oncology 26: 508-513.
  • Bonner, M.R., Han, D., Nie, J., Rogerson, P., Vena, J.E., Muti, P., Trevisan, M., Edge, S.B., and Freudenheim, J.L. ( 2005). Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiology, Biomarkers and Prevention 14: 53-60.
  • Bouker, K.B. and Hilakivi-Clarke, L. (2000). Genistein: Does it prevent or promote breast cancer? Environmental Health Perspectives 108: 701-708.
  • Bornehag, C.G., Sundell, J., Weschler, C.J., Sigsgaard, T., Lundgren, B., Hasselgren, M. (2004). The association between asthman and allergic symptoms in children and phthlates in house dust: A nested case-control study. Environmental Health Perspectives 112: 1393-1397.
  • Borgquist S, Anagnostaki L, Jirstom K, et al. (2007). Breast tumours following combined hormone replacement therapy express favorable prognostic factors. International Journal of Cancer 120:2202-2207.
  • Boyd, G.R., Reemtsma, H., Grimm, D.A., and Mitra, S. (2003). Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Science of Total Environment 311: 135-149.
  • Bradlow, H.L., Davis, D.L., Lin, G., Sepkovic, D., and Tiwari, R. (1995). Effects of pesticides on the ratio of 16 alpha/2-hydroxyestrone: a biologic marker of breast cancer risk. Environmental Health Perspectives 103: 147-150.
  • Brouwer, A., Longnecker, M.P., Birnbaum, L.S., Cogliano, J., Kostyniak, P., Moore, J., Schantz, S., and Winneke, G. (1999). Characterization of potential endocrine-related health effects at low-dose levels of exposure to PCBs. Environmental Health Perspectives 107: 639-649.
  • Brown, N.M., Manzolillo, P.A., Zhang, J.X., Wang, J., and Lamartiniere, C.A. (1998). Prenatal TCDD and predisposition to mammary cancer in the rat. Carcinogenesis 19: 1623-1629.
  • Byford, J.R., Shaw, L.E., Drew, M.G., Pope, G.S., Sauer, M.J., and Darbre, P.D. (2002). Oestrogenic activity of parabens in MCF7 human breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 80: 49-60.
  • C

  • Calaf, G.M., and Hei, T.K. (2000). Establishment of a radiationand estrogen-induced breast cancer model. Carcinogenesis 21: 769-776.
  • Centers for Disease Control and Prevention (CDC). (2005). Third national report on human exposure to environmental chemicals. Atlanta, GA: CDC. http://www.cdc.gov/exposurereport/
  • Charlier, C., Pitance, F., and Plomteux, G. (2003). PCB residues in a breast cancer patient population. Bulletin of Environmental Contamination and Toxicology 71: 887-891.
  • Charnley, G., and Doull, J. (2005). Human exposure to dioxins from food, 1999-2000. Food and chemical toxicology 43: 671-679.
  • Chiazze, L. and Ference, D. (1981). Mortality among PVC-fabricating employees. Environmental Health Perspectives 41: 137-143.and
  • Choe, S.Y., Kim, S.J., Kim, H.G., Lee, J.H., Choi, Y., Lee, H., and Kim, Y. (2003). Evaluation of estrogenicity of major heavy metals. Science of the Total Environment 312: 15-21.
  • Chumlea, W.C., Schubert, C.M., Roche, A.F., Kulin, H.E., et.al. (2003). Age at menarche and racial comparisons in US Girls. Pediatrics 111: 1101-113.
  • Chou Y.Y., Huang P.C,. Lee C.C,. et al. (2009). Phthalate exposure in girls during early puberty. Journal of Pediatric Endocrinology and Metabolism, 22:69-77.
  • Clemons, M.M. Loijens, L., and Goss, P. (2000). Breast cancer risk following irradiation for Hodgkin's disease. Cancer Treatment Reviews 26: 291-300
  • Collaborative Group on Hormonal Factors in Breast Cancer. (1996). Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 347: 1713-1727.
  • Collaborative Group on Hormonal Factors in Breast Cancer. (1997). Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350: 1047-1059.
  • Cohn B.A., Wolff M.A., Cirillo P.M., Sholtz R.I. (2007). DDT and breast cancer in young women: New data on the significance of age at exposure. Environmental Health Perspectives 115: 1406-1414.
  • Collaborative Group on Hormonal Factors in Breast Cancer. (2002). Breast cancer and breastfeeding: Collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50,302 women with breast cancers and 96,973 women without the disease. Lancet 360: 187-195.
  • Colon, I., Caro, D., Bourdony, C.J., and Rosario, O. (2000). Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environmental Health Perspectives 108: 895-900.
  • Consumer Reports. (1998). Hormone Mimics Hit Home. Consumer Reports 63: 52.
  • Coutelle, C., Hohn, B., Benesova, M., Oneta, C.M., Quattrochi, P., et.al. (2004). Risk factors in alcohol associated breast cancer. International Journal of Oncology 25: 1127-1132.
  • Czene, K., Lichtenstein, P. and Hemminki, K. (2002). Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. International Journal of Cancer 99: 260-266.
  • D

  • Darbre, P.D. (2003). Review article: Underarm cosmetics and breast cancer. Journal of Applied Toxicology 23: 89-95.
  • Darbe, P.D., Byford, J.R., Shaw, L.E., Horton, R.A., Pope, G.S., and Sauer, M.J. (2002). Oestrogenic activity of isobutylparaben in vitro and in vivo. Journal of Applied Toxicology 22: 219-226.
  • Darbre, P.D., Aljarrah, A., Miller, W.R., Coldham, N.G., Sauer, M.J., and Pope, G.S. (2004). Concentrations of parabens in human breast tumors. Journal of Applied Toxicology 24: 5-13.
  • Darbre, P.D. (2004b). Reply to Robert Golden and Jay Gandy. Journal of Applied Toxicology 24: 297-306.
  • Dees, C., Foster, J.S., Ahamed, S., and Wimalasena, J. (1997). Dietary estrogens stimulate human breast cancer cells to enter the cell cycle. Environmental Health Perspectives 105: 633-636.
  • Demers, A., Ayotter, P., Brisson, J., Dodin, S., Robert, J., and Dewailly, E. (2002). Plasma concentrations of polychlorinated biphenyls and the risk of breast cancer: A congener-specific analysis. American Journal of Epidemiology 155: 629-635.
  • Du, K., Chu, S., and Xu, X. (2000). Stimulation of MCF-7 cell proliferation by low concentrations of Chinese domestic polychlorinated biphenyls. Journal of Toxicology and Environmental Health 61: 201-207.
  • Dumeaux, V., Alsaker, E., and Lund, E. (2003). Breast Cancer and specific types of oral contraceptives: a large Norwegian cohort study. International Journal of Cancer 105: 844-850.
  • Durando M., Kass L., Piva J., Sonnenschein C., Soto A., Luque E., Munoz-de-Toro M. (2007). Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environmental Health Perspectives 115: 592-598.
  • E

  • Enoch R.R., Stanko J.P., Greiner S.N., Youngblood G.L., Rayer J.L., Fenton S.E. (2007). Mammary gland development as a sensitive endpoint after acute prenatal exposure to an atrazine metabolite mixture in female Long Evans rats. Environmental Health Perspectives 115: 5541-547.
  • Evans, N. (Ed.). (2006). State of the Evidence. San Francisco: Breast Cancer Fund and Breast Cancer Action.
  • F

  • Fisher, J.S. (2004). Environmental anti-androgens and male reproductive health: Focus on phthalates and testicular dysgenesis syndrome. Reproduction 127: 305-315.
  • Flarend, R., Bin, T., Elmore, D., and Hem, S.L. (2001). A preliminary study of dermal absorption of aluminum from antiperspirants using aluminum-26. Food and Chemical Toxicology 39: 163-168.
  • Frazier, A.L., Ryan, C.T., Rockett, H., Willett, W.C., and Colditz, G.A. (2003). Adolescent diet and risk of breast cancer. Breast Cancer Research 5: r59-r64.
  • Friedenreich, C.M. (2004). Physical activity and breast cancer risk: The effect of menopausal status. Exercise and Sport Sciences Reviews 32: 180-184.
  • Friedenreich, C.M., Btyant, H.E., and Courneya, K.S. (2001). Case-control study of lifetime physical activity and breast cancer risk. American Journal of Epidemiology 154: 336-347.
  • Friedenreich, C.M., and Orenstein, M.R. (2002). Physical activity and cancer prevention: Etiologic evidence and biological mechanisms. Journal of Nutrition 132.
  • Fung, T.T., Hu, F.B., Holmes, M.D., Rosner, B.A., Hunter, D.J., et.al. (2005). Dietary patterns and the risk of postmenopausal breast cancer. International Journal of Cancer 116: 116-121.
  • G

  • Gammon, M.D., Santella, R.M., Neugut, A.I., Eng, S.M., Teitelbaum, S.L., et.al. (2002). Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiology, Biomarkers and Prevention 11: 677-685.
  • Gammon, M.D., Eng, S.M., Teitelbaum, S.L., Britton, J.A., Kabat, G.C., et.al. (2004). Environmental tobacco smoke and breast cancer incidence. Environmental Research 96: 176-185.
  • Garcia-Morales, P., Saceda, M., Kenney, N., Kim, N., Salomon, D.S., Gottardis, M.M., Solomon, H.B., Sholler, P.F., Jordan, V.C., Martin, M.B. (1994). Effect of cadmium on estrogen-receptor levels and estrogen-induced responses in human breast cancer cells. Journal of Biological Chemistry 269: 16896-16901.
  • Giger, W., Brunner, P.H., and Schaffner, C. (1984). 4-Nonylphenol in sewage sludge: Accumulation of toxic metabolites from nonionic surfactants. Science 225: 623-625.
  • Gofman, J.W. (1995). Breast cancer and very-low-dose X-rays. The Lancet 346: 8991-8992.
  • Gofman, J.W., and O'Connor, E. (1996). Preventing Breast Cancer: The Story of a Major, Proven, Preventable Cause of this Disease. Committee for Nuclear Responsibility; 2nd edition.
  • Goldberg, M.S. and Labreche, F. (1996). Occupational risk factors for female breast cancer: A review. Occupational and Environmental Medicine 53: 145-156.
  • Golden, R., and Gandy, J. (2004). Letters to the Editor. Journal of Applied Toxicology 24: 297-298.
  • Goldin, B.R., Adlercreutz, H., Gorbach, S.L., Warram, J.H., Dwyer, J.T., Swenson, L., and Woods, M.N. (1982). Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. New England Journal of Medicine 307: 1542-1547.
  • Griffith, J. and Riggan, W.B. (1989). Cancer mortality in U.S. counties with hazardous waste sites and ground water pollution. Archives of Environmental Health 44: 69-74.
  • H

  • Hahn, W.C., and Weinberg, R.A. (2002). Rules for making human tumor cells. The New England Journal of Medicine 347: 1593-1603.
  • Hancock, S.L., Tucker, M.A., and Hoppe, R.T. (1993). Breast cancer after treatment of Hodgkin's disease. Journal of the National Cancer Institute 85: 25-31.
  • Hansen, J. (2000). Elevated risk for male breast cancer after occupational exposure to gasoline and vehicular combustion products. American Journal of Industrial Medicine 37: 349-352.
  • Harris, C.A., Henttu, P., Parker, M.G., and Sumpter, J.P. (1997). The estrogenic activity of phthalates in vitro. Environmental Health Perspectives 105: 802-811.
  • Heiss, G., Wallace, R., Anderson, G., et al. (2008). Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. Journal of the American Medical Association 299:1036-1045.
  • Hildreth, N.G., Shore, R..E., and Dvoretsky, P.M. (1989). The risk of breast cancer after irradiation of the thymus in infancy. The New England Journal of Medicine 321: 1281-1284.
  • Hill, P.K. and Yang, R. (2005). Breast cancer risk in Hispanic agricultural workers in California. International Journal of Occupational and Environmental Health 11:123-132.
  • Hoffman, D.A., Lonstein, J.E., Morin, M.M., Vissher, W., Harris, B.S., and Boice, B.D. (1989). Breast cancer in women with scoliosis exposed to multiple diagnostic X-rays. Journal of the National Cancer Institute 81: 1307-1312.
  • Hohenblum, P., Gans, O., Moche, W., Scharf, S., and Lorbeer, G. (2004). Monitoring of selected estrogenic hormones and industrial chemicals in groundwaters and surface waters in Austria. Science of the Total Environment 333: 185-193.
  • Hong, E., Ji, Y., Choi, K., Manabe, N., and Jeung, E. (2005). Conflict of estrogenic activity by various phthalates between in vitro and in vivo models related to the expression of calbindin-D9k. Journal of Reproduction and Development 51: 253-263.
  • Horn-Ross, P.L., John, E.M., Lee, M., Stewart, S.L., Koo, J., Sakoda, L.C., Shiau, A.C., Goldstein, J., Davis, P., and Perez-Stable, E.J. (2001). Phytoestrogen consumption and breast cancer risk in a multiethnic population: The Bay Area Breast Cancer Study. American Journal of Epidemiology 154: 434-441.
  • Hossaini, A., Larsen, J.J., and Larsen, J.C. (2000). Lack of oestrogenic effects of food preservatives (parabens) in uterotrophic assays. Food and Chemical Toxicology 38: 319-323.
  • Houle C.D., Ton T.V.T., Clayton N., Huff J., Hong H.H.L., Sills R.C. (2006). Frequent p53 and H-ras mutations in benzene- and ethyl oxide-induced mammary gland carcinomas from B6C3F1 mice. Toxicology Pathology 34: 752-762.
  • Howe, G.R., and McLaughlin, J. (1996). Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiation Research 145: 694-707.
  • Hoyer, A.P., Grandjean, P., Jorgensen, T., Brock, J.W., and Hartvig, H.B. (1998). Organochlorine exposure and rick of breast cancer. Lancet 352: 1816-1820.
  • Hsieh C.Y. , Santell R.C., Haslam S.Z., and Helferich W.G . (1998). Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Research 58: 3833-3838.
  • Hu, M., Yao, J., Cai, L., Bachman, K.E., Van Den Brule, F., Velculescu, V., and Polyak, K. (2005). Distinct epigenetic changes in the stromal cells of breast cancers. Nature Genetics 37: 899-905.
  • Hvas, L. (2001). Positive aspects of menopause: A qualitative study. Maturitas 39: 11-17.
  • I

  • Ibarluzea, J.M., Fernabdez, M.F., Santa-Marina, L., Olea-Serrano, M.F., Rivas, A.M., and Aurrekoetxea, J.J. (2004). Breast cancer and the combined effects of environmental estrogens. Cancer Causes and Control 15: 591-600.
  • Ionescu J.G., Novotny J., Stejskal V., Latsch A., Blaurock-Busch E., Eisenmann-Klein M. (2006). Increased levels of transition metals in breast cancer tissue. Neuroendocrinology Letters 27 (Suppl 1): 36-39.
  • Ingram, D., Sanders, K., Kolybaba, M., and Lopez, D. (1997). Case-control study of phyto-estrogens and breast cancer. Lancet 350: 990-994.
  • J

  • Jansen-Van Der Weide M (2009). Mammography screening and radiation-induced breast cancer among women with a familial or genetic predisposition: a metaanalysis. Published abstract of presentation at the 95th annual meeting of the Radiological Society of North America, Chicago.
  • Jeffy, B.D., Chirnomas, R.B., and Romagnolo, D.F. (2002). Epigenetics of breast cancer: Polycyclic aromatic hydrocarbons as risk factors. Environmental and Molecular Mutagenesis 39: 235-244.
  • Jenkins S, Rowell C, Wang J, et al. (2007). Prenatal TCDD exposure predisposes for mammary cancer in rats. Reproductive Toxicology 23:391-196.
  • John, E.M., Horn-Ross, P.L., and Koo, J. (2003). Lifetime physical activity and breast cancer risk in multiethnic population: The San Francisco Bay area breast cancer. Cancer Epidemiology Biomarkers and Prevention 12: 1143-1152.
  • John, E.M., Phipps, A.I., and Koo, J. (2005). Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiology Biomarkers and Prevention 14: 2905-2913.
  • Johnson, A.C. and Sumpter, J.P. (2001). Removal of endocrine-disrupting chemicals in activated sludge treatment works. Environmental Science and Technology 35: 4697-4703.
  • Johnson, C.J. (1984). Cancer incidence in an area of radioactive fallout down wind from the Nevada test site. Journal of the American Medical Association 251: 230-236.
  • Johnson, M.D., Kenney, N., Stoica, A., Hilakivi-Clarke, L., Singh, B., Chepko, G., Clarke, R., Sholler, P.F., Lirio, A.A., Foss, C., Reiter, R., Trock, B., Paik, S., and Martin, M.B. (2003). Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nature Medicine 9: 1081-1084.
  • Junk, G.A., Svec, H.J., Vick, R.D., and Avery, M.J. (1975). Contamination of water by synthetic polymer tubes. Environmental Science and Technology 8: 1100-1106.
  • K

  • Keinan-Boker, L., van der Schouw, Y.T., Grobbee, D.E., and Peeters, P.H. (2004). Dietary phytoestrogens and breast cancer risk. American Journal of Clinical Nutrition 79: 282-288.
  • Key, T.J., Appleby, P.N., Reeves, G.K., Roddam, A., Dorgan, J.F., et.al. (2003). Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. Journal of the National Cancer Institute 95: 1218-1226.
  • King, M.C., Marks, J.H., and Mandell, J.B. (2003). Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302: 643-646.
  • Kirova, Y.M., Vilcoq, J.R., Asselain, B., Sastre-Garau, X., and Fourquet, A. (2005). Radiation-induced sarcomas after radiotherapy for breast carcinoma. American Cancer Society 104: 856-863.
  • Kolpin, D.W., Furlong, E.T., Meyer, M.T., Thurman, E.M., Zaugg, S.D., Barber, L.B., and Buxton, H.T. (2002). Pharmaceuticals, hormones, and other organic wastewater contaminant in U.S. streams, 1999-2000: a national reconnaissance. Environmental Science and Technology 36: 1202-1211.
  • Krishnan, A.V., Stathis, P., Permuth, S.F., Tokes, L., and Felman, D. (1993). Bisphenol-A: An estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132: 2279-2286.
  • L

  • Labreche, F.P. and Goldberg, M.S. (1997). Exposures to organic solvents and breast cancer in women: A hypothesis. American Journal of Industrial Medicine 32: 1-14.
  • LaMerrill M, Kuruvilla BS, Pomp D, et al. (2009). Dietary fat alters body composition, mammary development, and cytochrome P450 induction after maternal TCDD exposure in DBA/2J mice with low-responsive aryl hydrocarbon receptors. Environmental Health Perspectives 117:1414-1419.
  • Land, C.E., Tokunaga, M., Koyama, K., Soda, M., et.al. (2003). Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990. Radiation Research 160: 707-717.
  • Lee S-A, Shu X-O, Li H, et al. (2009). Adolescent and adult soy food intake and breast cancer: Results from the Shanghai Women
  • Loi, S., Milne, R.L., Friedlander, M.L., McCredie, M.R.E., Giles, G.G., et.al. (2005) Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiology Biomarkers and Prevention 14: 1686-1691.
  • Longnecker, M.P., Newcomb, P.A., Mittendorf, R., Greenberg, E.R., Clapp, R.W., et.al. (1995). Risk of breast cancer in relation to lifetime alcohol consumption. Journal of the Natinal Cancer Institute 87: 923-929.
  • Loomis, D.P., Savitz, D.A., and Ananth, C.V. (1994). Breast cancer mortality among female electrical workers in the United States. Journal of the National Cancer Institute 86: 921-925.
  • Lopez-Cervantes, M., Torres-Sanchez, L., Tobias, A., and Lopez-Carrillo, L. (2004). Dichlorodiphenyldichloroethane burden and breast cancer risk: A meta-analysis of the epidemiological evidence. Environmental Health Perspectives 112: 207-214.
  • Lucier, G.W., Portier, C.J., and Gallo, M.A. (1993). Receptor mechanisms and dose-response models for the effects of dioxins. Environmental Health Perspectives 101: 36-44.
  • M

  • Ma H, Hill C, Bernstein L, Ursin G (2008). Low-dose medical radiation exposure and breast cancer risk in women under age 50 years overall and by estrogen and progesterone receptor status: Results from a case-control and a case-case comparison. Breast Cancer Research and Treatment 109:77-90.
  • Marchbanks, P.A., McDonald, J.A., Wilson, H.G., Folger, S.G., Mandel, M.G., Daling, J.R., Bernstein, L., Malone, K.E., Ursin, G., Strom, B.L., Norman, S.A., Wingo, P.A., Burkman, R.T., Berlin, J.A., Simon, M.S., Spirtas, R., and Weiss, L.K. (2002). Oral contraceptives and the risk of breast cancer. New England Journal of Medicine 346: 2025-2032.
  • Markey, C.M., Michaelson, C.L., Veson, E.C., Sonnenschein, C., and Soto, A.M. (2001). The mouse uterotrophic assay: A reevaluation of its validity in assessing the estrogenicity of bisphenol A. Environmental Health Perspectives 109: 55-60.
  • Martin, M.B., Reiter, R., Pham, T., Avellanet, Y.R., Camara, J., Lahm, M., Pentecost, E., Pratap, K., Gilmore, B.A., Divekar, S., Dagata, R.S., Bull, J.L., and Stoica, A. (2003). Estrogen-like activity of metals in MCF-7 breast cancer cells. Endocrinology 144: 2425-2436.
  • Mattsson, A., Ruden, B., Wilking, N., and Rutqvist, L.E. (1993). Radiation-induced breast cancer: Long-term follow-up of radiation therapy for benign breast disease. Journal of the National Cancer Institute 85: 1679-1685.
  • McMichael-Phillips, D.F., Harding, C., Morton, M., Roberts, S.A., Howell, A., Potten, C.S., and Bundred, N.J. (1998). Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. American Journal of Clinical Nutrition 68: 1431S-1435S.
  • McTiernan, A., Rajan, K.B., Tworoger, S.S., Irwin, M., Bernstein, L., et.al. (2003). Adiposity and sex hormones in postmenopausal breast cancer survivors. Journal of Clinical Oncology 21: 1961-1966.
  • Meerts, I.A., Letcher, R.J., Hoving, S., Marsh, G., Bergman, A., Lemmen, J.G., van der Burg, B., and Brouwer, A. (2001). In vitro estrogenicity of polybrominated diphenyl ethers, hydroxylated PDBEs, and polybrominated bisphenol A compounds. Environmental Health Perspectives 109: 399-407.
  • Merrill, R.M., Fugal, S., Novilla, L.B., and Raphael, M.C. (2005). Cancer risk associated with early and late maternal age at first birth. Gynecologic Oncology 96: 583-593.
  • Millikan, R.C., Player, J.S., deCotret, A.R., Tse, C., amd Keku, T. (2005). Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk. Cancer Epidemiol Biomarkers and Prevention 14: 2326-2334.
  • Million Women Study Collaborators. (2003). Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362: 419-427.
  • Mills, P.K. and Yang,, R. (2005). Breast cancer risk in Hispanic agricultrual workers in California. International Journal of Occupational and environmentl Health 11: 123-132.
  • Mohan, A.K., Hauptmann, M., Linet, M.S., et.al. (2002). Breast cancer mortality among female radiologic technologists in the United States. Journal of the National Cancer Institute 94: 943-948.
  • Moore, C.J., Eldridge, S.R., Tricomi, W.A., and Gould, M.N. (1987a). Quantitation of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene binding to nuclear macromolecules in human and rat mammary epithelial cells. Cancer Research 47: 2609-2613.
  • Moore, C.J., Pruess-Schwartz, D., Mauthe, R.J., Gould, M.N., and Baird, W.M. (1987). Interspecies differences in the major DNA adducts formed from benzo(a)pyrene but not 7, 12 dimethylbenz(a)anthracene in rat and human mammary cell cultures. Cancer Research 47: 4402-4406.
  • Moral R, Wang R, Russo IH, et al. (2008). Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signatures. J Endocrinol, 196:101-112.
  • Morimoto, L.M., White, E., Chen, Z., Chlebowski, R.T., Hays, J., et.al. (2002). Obesity, body size, and risk of postmenopausal breast cancer: The women's health initiative (United States). Cancer Causes and Control 13: 741-751.
  • Morin-Doody, M., Lonstein, J.E., Stovall, M., Hacker, D.G., Luckyanov, N., and Land, C.E. (2000). Breast cancer mortality after diagnostic radiography: Findings from the U.S. Scoliosis Cohort Study. Spine 25: 2052-2063.
  • Morin-Doody M, Freedman DM, Alexande BH, et al. (2006). Breast cancer incidence in U.S. radiologic technologists. Cancer 106:2707-2715.
  • N

  • National Research Council (1993). Pesticides in the Diets of Infants and Children, Washington, D.C.: National Academy Press.
  • National Research Council (2005). Health risks from exposure to low levels of ionizing radiation: BEIR VII phase 2. Washington, D.C.: National Academy Press.
  • Newman, L.A. (2005). Breast cancer in African-American women. The Oncologist 10: 1-14.
  • Nomura, D.H., Mateus, S.F., Saiki, M., and Bode, P. (2000). Characterization of inorganic components in plastic material. Journal of Radioanalytical and Nuclear Chemistry 244: 61-65.
  • O

  • Oakley, G.G., Devanaboyina, U., Robertson, L.W., and Gupta, R.C. (1996). Oxidative DNA damage induced by activation of polychlorinated biphenyls (PCBs): Implications for PCB-induced oxidative stress in breast cancer. Chemical Research in Toxicology 9: 1285-1292.
  • Oh MJ, Paul S, Kim SJ, et al. (2009). Comparative analysis of gene expression pattern after exposure to nonylphenol in human cell lines. Biochip Journal, 2:261-268.
  • P

  • Palli, D., Masala, G., Mariami-Costantini, R., Zanna, I., Saieva, C., Sera, F., Decarli, A., and Ottini, L. (2004). A gene-environment interaction between occupation and BRCA1/BRCA2 mutations in male breast cancer? European Journal of Cancer 40: 2474-2479.
  • Parkin, D.M. (1994). Cancer in developing countries. Cancer Surveys 19-20: 519-561.
  • Parkin, D.M., Pisani, P., and Ferlay, J. (1999). Estimates of the worldwide incidence of 25 major cancers in 1990. International Journal of Cancer 80: 827-841.
  • Patel, A.V., Calle, E.E., Bernstein, L., Wu, A.H., and Thun, M.J. (2003). Recreational physical activity and risk of postmenopausal breast cancer in a large cohort of US women. Cancer Causes and Contro 14: 519-529.
  • Payne, J., Scholze, M., and Kortenkamp, A. (2001). Mixtures of four organochlorines enhance human breast cancer cell proliferation. Environmental Health Perspectives 109: 391-397.
  • Petralia, S.A., Vena, J.E. Freudenheim, J.L., Dosemeci, M., Michalek, A., and Goldberg, M.S. (1999). Risk of premenopausal breast cancer in association with occupational exposure to polycyclic aromatic hydrocarbons and benzene. Scandinavian Journal of Work and Environmental Health 25: 215-221.
  • Petreas, M., She, J., Brown, F.R., Winkler, J., Windham, G., Rogers, E., Zhao, G., Bhatia, R., and Charles, M.J. (2003). High body burdens of 2,2',4,4'-tetrabromodiphenyl ether (BDE-47) in California women. Environmental Health Perspectives 111: 1175-1179.
  • Picard, K., Lhuguenot, J.C., Lavier-Canivenc, M.C., and Chagnon, M.C. (2001). Estrogenic activity and metabolism of n-butyl benzyl phthalate in vitro: Identification of the active molecule(s). Toxicology and Applied Pharmacy 172: 108-118.
  • Poschl, G., and Seitz, H.K. (2004). Alcohol and cancer. Alcohol and Alcoholism 39: 155-165.
  • Preston, D.L., Mattsson, A., Holmberg, E., et.al. (2002). Radiation effects on breast cancer risk: A pooled analysis of eight cohorts. Radiation Research 158: 220-235.
  • Pugazhendhi, D., Pope, G.S., and Darbre, P.D. (2005). Oestrogenic activity of p-hydroxybenzoic acid (common metabolite of paraben esters) and methylparaben in human breast cancer cell lines. Journal of Applied Toxicology 25: 301-309.
  • Pulgar, R., Olea-Serrano, M.F., Novillo-Fertrell, A., Rivas, A., Pazos, P., Pedraza, V., Navajas, J.M., and Olea, N. (2000). Determination of bisphenol A and related aromatic compounds released from bis-GMA-based composites and sealants by high performance liquid chromatography. Environmental Health Perspectives 108: 21-27.
  • R

  • Raffensperger, C. and Tickner, J.A. (1999). Protecting Public Health and the Environment: Implementing the precautionary principle, Washington, D.C.: Island Press.
  • Rahman, F., Langford, K.H., Scrimshaw, M.D., and Lester, J.N. (2001). Polybrominated diphenyl ether (PBDE) flame retardants. The Sciencer of the Total Environment 275: 1-17.
  • Rajapakse, N., Silva, E., Scholza, M., and Kortenkamp, A. (2004). Deviation from additivity with estrogenic mixtures containing 4-nonylphenol and 4-tert-octylphenol detected in the E-SCREEN assay. Environmental Science and Technology 38: 6343-6352.
  • Rebbeck, T.R. (2002). Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. European Journal of Cancer 38.
  • Reeves GK, Beral V, Green J, et al. (2006). Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncology 7:910-918.
  • Rennix, C.P., Quimnn, M.M., Amoroso, P.J., Eisen, E.A., and Wegman, D.H. (2005). Risk of breast cancer among enlisted army women occupationally exposed to volatile organic compounds. American Journal of Industrial Medicine 48: 157-167.
  • Richter, W.O. (2003). Fatty acids and breast cancer: is there a relationship? European Journal of Medical Research 8: 373-380.
  • Romieu, I, Lazcano-Ponce, E., Sanchez-Zamorano, L.M., Willett, W., and Hernandez-Avila, M. (2004). Carbohydrates and the risk of breast cancer among Mexican women. Cancer, Epidemiology Biomarkers and Prevention 13: 1283-1289.
  • Ron, E., Ikeda, T., Preston, D.L., and Tokuoka, S. (2005). Male breast cancer incidence among atomic bomb survivors. Journal of the National Cancer Institute 97: 603-605.
  • Ross, R.K., Paganini-Hill, A., Wan, P.C., and Pike, M.C. (2000). Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin. Journal of the National Cancer Institute 92: 328-332.
  • Routledge, E.J., Parker, J., Odum, J., Ashby, J., and Sumpter, J.P. (1998). Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicology and Applied Pharmacology 153: 12-19.
  • Rudel, R.A., Melly, S.J., Geno, P.W., Sun, G., and Brody J.G. (1998). Identification of alkylphenols and other estrogenic phenolic compounds in wastewater, septage, and groundwater on Cape Cod, Massachusetts. Environmental Science and Technology 32: 861-869.
  • Rudel, R.A., Brody, J.G., Spengler, J.D., Vallarino, J., Geno, P.W., Sun, G., and Yau, A. (2001). Identification of selected hormonally active agents and animal mammary carcinogens in commercial and residential air and dust samples. Journal of the Air and Waste Management Association 51: 499-513.
  • Rudel, R.A., Camann, D.E., Spengler, J.D., Korn, L.R., and Brody, J.G. (2003). Phthalates, alkylphenols, pesticides, polybrominated diphenyl ethers, and other endocrine-disrupting compounds in indoor air and dust. Environmental Science and Technology 37: 4543-4553.
  • Russo, I.H. and Russo, J. (1998). Role of hormones in mammary cancer initiation and progression. Journal of Mammary Gland Biology and Neoplasia 3: 49-61.
  • S

  • Sagiv SK, Gaudet MM, Eng SM, et al. (2009). Polycyclic aromatic hydrocarbon-DNA adducts and survival among women with breast cancer. Environmental Research 109:287-291.
  • Schairer, C., Lubin, J., Troisi, R., Sturgeon, S., Brinton, L. and Hoover, R. (2000). Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. Journal of the American Medical Association 283: 485-491.
  • Schiliro, T., Pignata, C., Fea, E., and Gilli, G. (2004). Toxicity and estrogenic activity of a wastewater treatment plant in northern Italy. Archives of Environmental Contamination and Toxicology 47: 456-462.
  • Schuetz F, Diel IJ, Pueschel M, et al. (2007). Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy. American Journal of Obstetrics and Gynecology 196:e1-9.
  • Seifert A, Helge T, Homback-Klonisch S, et al. (2009). TCDD mediates inhibition of p53 and activation of Era signaling in MCF-7 cells at moderate hypoxic conditions. International Journal of Oncology 35:417-424.
  • Shore, R.E., Hildreth, N., Woodard, E., Dvoretsky, P., et.al. (1986). Breast cancer among women given X-ray therapy for acute postpartum mastitis. Journal of the National Cancer Institute 77: 689-696.
  • Shu, X.O., Jin, F., Dai, Q., Wen, W., Potter, J.D., Kushi, L.H., Ruan, Z., Gao, Y.T., and Zheng, W. (2001). Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiology, Biomarkers and Prevention 10: 483-488.
  • Shu XO, Zheng Y, Cai H, et al (2009). Soy food intake and breast cancer survival. Journal of the American Medical Association 302:2437-2443.
  • Sigurdson AJ, Bhatti P, Chang S-C, et al (2009). Polymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among US radiologic technologists. Breast Cancer Research and Treatment 118:177-184.
  • Silva, M.J., Rajapakse, N., and Kortenkamp, A. (2002). Something from 'nothing': Eight week estrogenic chemicals combined at concentrations below NOEOs produce significant mixture effects. Environmental Science Technology 36: 1751-1756.
  • Silva, M.J., Barr, D.B., Reidy, J.A., Malek, N.A., Hodge, C.C., Caudill, S.P., Brock, J.W., Needham, L.L., and Calafat, A.M. (2004). Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environmental Health Perspectives 112: 331-338.
  • Simon SL, Weinstock RM, Doody MM, et al. (2006). Estimating historical radiation doses to a cohort of U.S. radiologic technologists. Radiation Research 166:174-192.
  • Smith-Warner, S.A., Spiegelman, D., Yaun, S.S., Van Den Brandt, P.A., Folsom, A.R., et.al. (2003). Alcohol and breast cancer in women: A pooled analysis of cohort studies. Journal of the American Medical Association 279: 535-540.
  • Snedeker, S. M. (2001). Pesticides and breast cancer risk: A review of DDT, DDE and dieldrin. Environmental Health Perspectives 109 Suppl. 1: 35-47.
  • Snedeker, S.M. and Diaugustine, R.P. (1996). Hormonal and environmental factors affecting cell proliferation and neoplasia in the mamary gland. Progress in Clinical and Biological Research 394: 211-253.
  • Sorensen, T.I.A., Nielsen, G.G., Anderson, P.K., and Tesdale, T.W. (1988). Genetic and environmental influences on premature death in adult adoptees. The New England Journal of Medicine 318: 727-732.
  • Soto, A.M., Justicia, H., Wray, J.W., and Sonnenschein, C. (1991). P-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene. Environmental Health Perspectives 92: 167-173.
  • Soto AM, Chung KL, Sonnenschein C (1994). The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environmental Health Perspectives 102:380-383.
  • Spink, B.C., Pang, S., Pentecost, B.T., Spink, D.C. (2002). Induction of cytochrome P450 1B1 in MDA-MB-231 human breast cancer cells by non-ortho-substituted polychlorinated biphenyls. Toxicology in Vitro 16: 695-704.
  • Stahlberg, C., Pedersen, A.T., Lynge, E., Andersen, Z.J., Keiding, N., Hundrup, Y.A., Obel, E.B., and Ottesen, B. (2004). Increased risk of breast cancer following different regiments of hormone replacement therapy frequently used in Europe. International Journal of Cancer 109: 721-727.
  • Staples, C.A., Peterson, D.R., Parkerton, T.F., and Adams, W.J. (1997). The environmental fate of phthalate esters: A literature review. Chemosphere 35: 667-749.
  • Stapleton, H.M., Dodder, N.G., Offenberg, J.H., Schantz, M.M., and Wise, S.A. (2005). Polybrominated diphenyl esters in house dust and clothes dryer lint. Environmental Science and Technology 39: 925-931.
  • Stoll, B.A. (1998). Western diet, early puberty, and breast cancer risk. Breast Cancer Research and Treatment 49: 187-193.
  • Storm, H.H., Andersson, M., Boice, J.D., Blettner, M, et.al. (1992). Adjuvant radiotherapy and risk of contralateral breast cancer. Journal of the National Cancer Institute 84: 1245-1250.
  • Struewing, J.P. (2004). Genomic approaches to identifying breast cancer susceptibility factors. Breast Dis 19: 3-9.
  • T

  • Tham, D.M., Gardner, C.D., and Haskell, W.L. (1998). Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence. Journal of Clinical Endocrinology and Metabolism 83: 2223-2235.
  • Thomas, D.B., Rosenblatt, K., Jimenez, L.M., McTiernan, A., et.al. (1994). Ionizing radiation and breast cancer in men (United States). Cancer Causes and Control 5: 9-14.
  • Tickner, J.A., Schettler, T., Guidotti, T., McCally, M., and Rossi, M. (2001). Health risks posed by use of Di-2-ethylhexyl phthlate (DEHP) in PVC medical devices: a critical review. American Journal of Industrial Medicine 39: 100-111.
  • Tlsty, T.D., Crawford, Y.G., Holst, C.R., Fordyce, C.A., Zhang, J., et.al. (2004). Genetic and epigenetic changes in mammary epithelial cells may mimic early events in carcinogenesis. Journal of Mammary Gland Biology and Neoplasia 9: 263-274.
  • Tiwary, C.M. (1998). Premature sexual development in children following the use of estrogen or placenta-containing hair products. Clinical Pediatrics 37: 733-739.
  • Tiwary, C.M., Ward, J.A. (2003). Use of hair products containing hormone or placenta by US military personnel. Journal of Pediatric Endocrinology and Metabolism, 16: 1025-1032.
  • Travis, L.B., Hill, D.A., Dores, G.M., Gospodarowicz, M., van Leeuwen, F.E., Holowaty, E., Glimelius, B., Andersson, M., Wiklund, T., Lynch, C.F., van
  • Trombino, A.F., Near, R.I., Matulka, R.A., Yang, S., Hafer, L.J., Toselli, P.A., Kim, D.W., Rogers, A.E., Sonenshein, G.E. and Sherr, D.H. (2000). Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesis Breast Cancer Research and Treatment 63: 117-131.
  • Turnbull C., Mirugaesu N., Eeles R. (2006). Radiotherapy and genetic predisposition to breast cancer. Clinical Oncology 18: 257-267.
  • Tward, J.D., Wendland, M.M., Shrieve, D.C., Szabo, A., Gaffney, D.K. (2006). The risk of secondary malignancies over 30 years after the treatment of Non-Hodgkin Lymphoma. Cancer 107: 108-115.
  • U

  • Ursin, G., Bernstein, L., Wang, Y., Lord, S.J., Deapen, D., et.al. (2004). Reproductive factors and risk of breast carcinoma in a study of white and African-American Women. Cancer 101: 353-362.
  • V

  • Valeron PF, Pestano JJ, Luzardo OP, et al. (2009). Differential effects exerted on human mammary epithelial cells by environmentally relevant organochlorine pesticides either individually or in combination. Chemico-Biological Interactions 180:485-491.
  • Vandenberg L.N., Maffini M.V., Wadia P.H., Sonnenschein C., Rubin B.S., Soto A.M. (2007). Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology 148: 116-127
  • Van Leeuwen, F.E., Klokman, W.J., Stovall, M. Dahler, E.C., et.al. (2003). Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. Journal of the National Cancer Institute 95: 971-980.
  • Verkooijen HM, Bouchardy C, Vinh-Hung V, et al. (2009). The incidence of breast cancer and changes in the use of hormone replacement therapy: A review of the evidence. Maturitas, 64:80-85.
  • Vorderstrasse, B.A., Fenton, S.E, Bohn, A.A., Cundiff, J. A., and Lawrence, B.P. (2004). A novel effect of dioxin: Exposure during pregnancy severely impairs mammary gland differentiation. Toxicological Sciences 78: 248-257.
  • W

  • Walker, N.J., Crockett, P.W., Nyska, A., Brix, A.E., Jokinen, M.P., Sells, D.M., Hailey, J.R., Easterling, M., Haseman, J.K., Yin, M., Wyde, M.E., Bucher, J.R., and Portier, C.J., (2005). Dose-additive carcinogenicity of a defined mixture of 'dioxin-like compounds'. Environmental Health Perspective 113: 43-48.
  • Wang, D.Y., Allen, D.S., DeStavola, B.L., Fentiman, I.S., et.al. (2000). Urinary androgens and breast cancer risk: Results from a long-term prospective study based in Guernsey. British Journal of Cancer 82: 1577-1584.
  • Wang, T.T., Sathyamoorthy, N., and Phang, J.M. (1996). Molecular effects of genistein of estrogen receptor mediated pathways. Carcinogenesis 17: 271-275.
  • Wang, J.X., Zhang, L.A., Li, B.X., et.al. (2002). Cancer incidence and risk estimation among medical x-ray workers in China 1950-1995. Health Physics 82: 455-466.
  • Warner, M., Eskenazi, B., Mocarelli, P., Gerthoux, P.M., Samuels, S., Needham, L., Patterson, D., and Brambilla, P. (2002). Serum dioxin concentrations and breast cancer risk in the Seveso Women's Health Study. Environmental Health Perspectives 110: 625-628.
  • White, R., Jobling, S., Hoare, S.A., Sumpter, J.P., and Parker, M.G. (1994). Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology 135: 175-182.
  • Winchester, D.P., Osteen, R.T., and Menck, H.R. (1996). The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer 78: 1838-1843.
  • Women's Health Initiative Investigators. (2002). Risks and benefits of estrogen plus progestin in health postmenopausal women: Principal results from the Women's Health Initiative Randomized Controlled Trial. Journal of the American Medical Association 288: 321-333.
  • Wu H.D.I., Chou S.Y., Chen D.R., Kuo H.W. (2006). Differentiation of serum levels of trace elements in normal and malignant breast patients. Biological Trace Element Research 113: 9-18.
  • Y

  • Yuan, J.M., Wang, Q.S., Ross, R.K., Henderson, B.E., and Yu, M.C. (1995). Diet and breast cancer in Shanghai and Tianjin, China. British Journal of Cancer 71: 1353-1358.
  • Z

  • Zhang, R.Y., Liu, Y., Pang, D.W., Cai, R.X., and Qi, Y.P. (2002). Spectroscopic and voltametric study on the binding of aluminum(III) to DNA. Japan Society for Analytical Chemistry 18: 761-766.
  • Zhang M, Yang H, Holman CD (2009). Dietary intake of isflavones and breast cancer risk by estrogen and progesterone receptor status. Breast Cancer Research and Treatment 118:553-563.
  • Ziegler, R.G., Hoover, R.N., Pike, M.C., Hildesheim, A., et. al. (1993). Migration patterns and breast cancer risk in Asian-American women. Journal of the National Cancer Institute 85: 1819-1827.